The Na ϩ /I Ϫ symporter (NIS) is important in hormone synthesis in the thyroid gland. NIS activity, as reflected by I Ϫ uptake, was increased by TSH (1 mU/mL) or forskolin (10 mol/L) in primary cultured human thyroid cells. Northern blot analysis revealed that incubation of these cells with TSH or forskolin for 24 h increased the abundance of NIS messenger ribonucleic acid (mRNA) 2.3-and 2.5-fold, respectively. Immunoblot analysis revealed 2.7-and 2.4-fold increases, respectively, in the amount of NIS protein after 48 h, suggesting that elevated levels of intracellular cAMP induced the expression of NIS in human thyrocytes. We then studied the levels of
T HE TRANSPORT of iodide (I Ϫ ) into thyroid cells is required for the synthesis of thyroid hormone (1). Intracellular I
Ϫ is subsequently incorporated into thyroglobulin (Tg) in a reaction that is catalyzed by thyroid peroxidase (TPO). Both this reaction and I Ϫ transport are stimulated by TSH. The Na ϩ /I Ϫ symporter (NIS) plays an important role in I Ϫ transport into the thyroid follicular cells. However, the molecular mechanism in the regulation of NIS by TSH remained unclear because neither the gene nor the protein of NIS had been identified. On the other hand, it is known that I Ϫ uptake activity is increased in patients with Graves' disease (2) and that patients with congenital goiter caused by hypothyroidism reportedly exhibit a partial defect of I Ϫ transport (3) (4) (5) . Thus, NIS seems to be implicated in the pathogenesis and development of these diseases.
Dai et al. (6) have recently cloned and characterized the complementary DNA (cDNA) for rat NIS. Subsequently, using recombinant rat NIS protein, we reported that some patients with autoimmune thyroid disease, such as Hashimoto's thyroiditis and Graves' disease, might possess an autoantibody against NIS and that the IgGs from patients with Hashimoto's thyroiditis could affect NIS activity reflected by I Ϫ uptake (7, 8) . We have now cloned and sequenced the human NIS cDNA that contains the entire coding sequence and examined the effect of TSH on NIS messenger ribonucleic acid (mRNA) and protein in cultured human thyroid cells as well as measured NIS mRNA and protein in normal and Graves' thyroid tissues in the present study.
Materials and Methods

Cell cultures
Thyroid tissue was obtained from a patient with Graves' disease who underwent a subtotal thyroidectomy. The diagnosis of Graves' disease was based on conventional criteria (diffuse goiter, hyperthyroidism, and exophthalmos); TSH binding inhibitor immunoglobulin (TBII) activity was 26% before surgery. Protocols were approved by the institutional ethics board of Yamanashi Medical University. Thyroid cells were prepared and cultured as described previously (9 -12) . In brief, thyroid tissue was digested with collagenase type II (1 mg/mL; Sigma Chemical Co., St. Louis, MO) and dispase II (5 mg/mL; Boehringer Mannheim, Mannheim, Germany). After being centrifuged, resuspended, and washed three times, follicles were seeded in 24-well culture plates or 10-cm culture dishes and cultured in Coon's modified Ham's F-12 medium (Sigma) containing insulin (10 g/mL), transferrin (5 g/mL), somatostatin (10 ng/mL), hydrocortisone (10 nmol/L), glycyl-l-histidyl-l-lysine (10 ng/mL), TSH (5 mU/mL; Sigma), penicillin (100 U/mL), streptomycin (100 g/mL), and amphotericin B (2.5 g/mL). If indicated, 1% calf serum (Life Technologies, Grand Island, NY) was also added to the medium. The cells were incubated for 2 days and then maintained for 5 days in the same medium lacking TSH (5H medium). Culture medium was replaced every other day. The cells were then incubated for the indicated times in 5H medium containing TSH (1 mU/mL), forskolin (10 mol/L), mercaptomethylimidazol (MMI; 1 mmol/L), or TSH (1 mU/mL) plus MMI (1 mmol/L) before measurement of I Ϫ uptake or NIS mRNA or protein. 3)] and then incubated for 2 h at 37 C with 100 nmol/L 125 I Ϫ (50 mCi/mmol) in the same buffer (9, 13) . The cells were rapidly rinsed and scraped from each well, and the associated radioactivity was measured with a ␥-counter. The radioactivity was normalized to the cellular protein content measured in the same cells. For the assay of I Ϫ uptake in CHO-K1 cells transfected with human NIS cDNA in pcDNA3 (Invitrogen, San Diego, CA), the cells were incubated with the same I Ϫ uptake buffer containing 125 I Ϫ for the indicated times as described previously (7).
Iodide uptake
Cloning and sequencing of human NIS cDNA
We screened 1 million independent recombinant bacteriophage from a human thyroid follicular carcinoma cDNA library in gt11 (HL1009b, Clontech, Palo Alto, CA) with a rat NIS cDNA probe as described previously (7) . Inserts from purified recombinant bacteriophage obtained from four rounds of library screening (14) were excised with EcoRI (Takara, Ohtsu, Japan) and subcloned into pBluescript SK ϩ (Stratagene, La Jolla, CA). Cloned inserts were subcloned into the M13 mp18 phage vector and sequenced.
Northern blot analysis
Total RNA (15 g) from cultured cells or from specimens of five normal and five Graves' human thyroids (obtained from patients undergoing hemithyroidectomy for benign adenoma or papillary cancer, or subtotal thyroidectomy for Graves' disease; TBII activities in Graves' patients ranged from 56.0 -66.3%) was separated on a 1% agarose gel containing formaldehyde and transferred to a nylon filter as described previously (15) . A human NIS RNA probe was prepared by the in vitro transcription of pcDNA3 containing the human NIS cDNA with SP6 RNA polymerase (Pharmacia LKB, Tokyo, Japan). Other probes were prepared by labeling cDNAs corresponding to rat ␤-actin, human TPO, rat Tg, and human TSH receptor (TSHR) as previously described (16) . The filters were hybridized with the probes and washed, and mRNA signals were quantitated with a BAS2000 system (Fujix, Tokyo, Japan).
Immunoblot analysis
Membrane fractions were prepared from cultured cells or thyroid tissue in a solution containing 10 mmol/L Tris-HCl (pH 7.4), 5 mmol/L NaCl, 1 mmol/L ethylenediamine-N,N,NЈ,NЈ-tetraacetic acid, 1 mmol/L phenylmethylsulfonylfluoride, and leupeptin (50 g/mL); subjected to electrophoresis on a 10% polyacrylamide gel containing 0.1% SDS; and transferred to a nitrocellulose filter. Immunoblot analysis was performed with antiserum (1:500) generated with glutathione-Stransferase/N-terminal portion of rat NIS (amino acids 1-231) fusion protein as described previously (7, 8) . The abundance of immunoreactive human NIS was quantitated with a scanning densitometer (model GT-8000, Epson, Tokyo, Japan).
Statistical analysis
Data are presented as the mean Ϯ se and were analyzed by Student's t test or linear regression. When multiple comparisons were made, statistical significance was determined by ANOVA with the Bonferroni/ Dunn post-hoc test. P Ͻ 0.05 was considered statistically significant.
Results
Iodide uptake by cultured cells
The uptake of I Ϫ by cultured human thyroid cells was stimulated by the addition of TSH (1 mU/mL) or forskolin (10 mol/L) in a time-dependent manner ( Fig. 1) , consistent with previous observations (9, 10, 13). Cells exposed to 1% calf serum during culture showed a reduced response to TSH (data not shown), again as demonstrated previously (9, 10) . MMI had no effect on I Ϫ uptake in the absence or presence of TSH.
Cloning of human NIS
We were unsuccessful in our attempt to detect human NIS mRNA by Northern blot analysis with rat NIS cDNA as a probe, which thus necessitated the cloning of human NIS cDNA. Screening of a human thyroid follicular carcinoma cDNA library with rat NIS cDNA identified an approximately 1.6-kilobase (kb) insert that contained 240 bp of the 5Ј-untranslated region and 1333 bp of the open reading frame of human NIS cDNA. We then screened the library with the cloned 1.6-kb DNA fragment as a probe and obtained an approximately 2.4-kb cDNA that contained the entire coding sequence. The 1929-bp open reading frame encodes a protein of 643 amino acids, as previously described (17) . Figure 2 shows replacements of nucleotide and deduced amino acids in our findings. Three amino acid substitutions were found: Pro 102 , Gln 536 , and Gln 556 instead of Ala, Thr, and Ser, respectively. Other nucleotide replacements were T (at the position of 307, A in ATG initiation codon is designated 1), G (1338), and G (1548) instead of C, C, and A, respectively, with no amino acid substitutions. CHO-K1 cells transfected with the cloned human NIS cDNA showed marked I Ϫ uptake activity, whereas CHO-K1 cells transfected with the pcDNA3 alone did not have I Ϫ uptake (Fig. 3) .
Regulation of human NIS mRNA and protein in cultured cells
As shown in Fig. 1 , TSH (1 mU/mL) and forskolin (10 mol/L) up-regulated I Ϫ uptake activity, so we determined human NIS mRNA levels in the presence of these agents. Northern blot analysis of total RNA from cultured human thyroid cells with a human NIS RNA probe revealed marked hybridization with an approximately 3.5-kb mRNA (Fig. 4A) . Incubation of cells for 24 h with TSH or forskolin increased the amount of NIS mRNA 2.3-and 2.4-fold, respectively (Fig.  4) . MMI (1 mmol/L) had little effect on NIS mRNA abun-
FIG. 1. Uptake of I
Ϫ by cultured human thyrocytes. The cells were seeded and cultured without serum. After incubation for 5 days in 5H medium (without TSH), cells were incubated for the indicated times in the same medium containing TSH (1 mU/mL; E), forskolin (10 mol/L; ‚), MMI (1 mmol/L; F), TSH plus MMI (OE), or no additives (f). I Ϫ uptake was then determined as described in Materials and Methods. Data are the mean Ϯ SE of triplicate wells. *, P Ͻ 0.005 vs. control (no additives), by Bonferroni/Dunn post-hoc test.
dance. Immunoblot analysis with antiserum to rat NIS detected an approximately 77-kDa immunoreactive protein in cultured human thyroid cells, consistent with our previous observations (7); weak signals were detected at 88 and 60 kDa, but these were also apparent with serum preadsorbed with rat NIS, whereas 77-kDa protein disappeared (Fig. 4A,  lane f) . Incubation of cells with TSH or forskolin for 48 h increased the amount of NIS protein 2.7-and 2.4-fold, respectively. MMI had no effect on the abundance of human NIS protein.
Northern blot analysis of human NIS in normal and Graves' thyroid tissues
As human NIS was up-regulated by TSH and forskolin in these experiments, it was expected that the expression of human NIS was increased in Graves' thyroid compared with that in normal thyroid. Northern blot analysis revealed the amounts of NIS mRNA in thyroid tissue from five patients with Graves' disease to be markedly greater than those in five specimens of normal thyroid tissue (Fig. 5A) . The abundance of both TPO and Tg mRNAs, but not that of TSHR mRNA, also appeared increased in Graves' thyroid tissue. Quantitative densitometry and normalization of the amounts of EXPRESSION OF THE Na ϩ /I Ϫ SYMPORTERNIS, TPO, Tg, and TSHR mRNAs relative to the amount of ␤-actin mRNA revealed significant increases of approximately 3.8-and 2.9-fold in NIS and TPO mRNAs, respectively, in Graves' thyroid tissue (Fig. 5B) . Then we studied the correlation between the expression levels of these thyroid-specific genes. The amount of NIS mRNA in all tissue specimens was significantly correlated with those of TPO and Tg mRNAs (Fig. 5C) ; there was also a significant correlation between the amounts of TPO and Tg mRNAs, but not between the amount of TSHR mRNA and that of NIS, TPO, or Tg mRNA (r ϭ 0.282, r ϭ 0.107, and r ϭ 0.104, respectively).
Immunoblot analysis of NIS in normal and Graves' thyroid tissue
Immunoblot analysis of membrane fractions prepared from three normal and four Graves' thyroid specimens was performed with antiserum to rat NIS. The amount of NIS protein in Graves' thyroid specimens was 3.1 times that in normal thyroid tissue (Fig. 6) .
Discussion
TSH/cAMP has previously been shown to stimulate I Ϫ uptake in both the continuous rat thyroid cell line FRTL-5 and primary cultures of human thyroid cells (9, 10, 13). Our 5) and Graves' (lanes 6 -10) thyroid tissue was subjected to Northern analysis with probes specific for NIS, TPO, Tg, TSHR, or ␤-actin mRNA as indicated. B, The amounts of NIS, TPO, Tg, and TSHR mRNAs were quantitated by densitometry and expressed relative to the amount of ␤-actin mRNA. Data are the mean Ϯ SE (n ϭ 5). *, P Ͻ 0.01; **, P Ͻ 0.05 (vs. normal, by Student's t test). C, Correlation analysis of the relations among the normalized amounts of NIS, TPO, Tg, and TSHR mRNAs in normal (E) and Graves' (F) thyroid specimens.
demonstration that TSH and forskolin increased I Ϫ uptake by cultured human thyroid cells is thus consistent with these previous observations. Serum-free cultures of human cells responded well to TSH and forskolin in a time-dependent manner. The presence of 1% serum reduced I Ϫ uptake stimulated by TSH as described previously (9, 10) . These data suggest that our cultures followed the previous experiments (9, 10) and were thought to be valid. MMI, known to be a goitrogen in vivo, had no effect on I Ϫ uptake directly in the primary cultured cells. Incubation for I Ϫ uptake was usually performed for 40 -120 min in primary cultured human thyroid cells, as described previously (9, 10, 18, 19) . Two-hour incubation for I Ϫ steady state uptake could reflect not only I Ϫ transport, but also other factors, such as backflux rate by nonspecific leak, cell water content, and protein binding; however, the major part of the uptake activity could reflect I Ϫ transport stimulated by TSH/forskolin. Therefore, we next determined NIS expression, which may be involved in the increase in I Ϫ uptake. We also cloned human NIS cDNA and detected three differences in the deduced amino acid sequence from that determined by Smanik et al. (17) . These differences in amino acids might not appear to affect I Ϫ uptake activity, given the marked activity in cells transfected with our cloned entire NIS cDNA, and may possibly represent polymorphisms.
TSH and forskolin up-regulate NIS mRNA and protein in FRTL-5 cells, actions that may underlie at least in part the effect of the agents on I Ϫ uptake activity (20) ; NIS mRNA was markedly increased after 24 h and NIS protein after 48 h of incubation with TSH. We have now shown that TSH and forskolin markedly increased the amounts of NIS mRNA and protein in primary cultured human thyroid cells at these same time points. Thus, the TSH/cAMP pathway appears to up-regulate NIS gene expression and NIS protein abundance, resulting in an increase in I Ϫ uptake activity in human thyroid cells.
In individuals with Graves' disease, an up-regulation of thyroid function, as reflected in increased uptake of I Ϫ (2) and increased hormone production as a result of increased H 2 O 2 generation and synthesis of TPO and Tg (21-23), appears to contribute to both the progression and duration of the disease. We have now shown that the amounts of NIS mRNA and protein are increased in thyroid tissue from Graves' patients. The significant correlation between the abundance of NIS mRNA and that of TPO or Tg mRNAs in normal and Graves' thyroid tissue suggests that NIS may be a marker of thyroid cell differentiation. We have previously shown that the amounts of Tg and TSHR mRNAs are reduced in neoplastic thyroid tissue relative to those in normal thyroid, suggesting that the abundance of these mRNAs reflects the extent of tissue differentiation (16) . Therefore, NIS mRNA expression should be determined not only in Graves' thyroid but also in benign and malignant neoplasms. The correlation between NIS and TPO or Tg mRNAs also suggests that the mechanism of NIS gene expression might be similar to that of the TPO and Tg genes. The expression of TPO and Tg genes is stimulated by a cAMP pathway in primary cultures of human thyroid cells (24, 25) . Given the marked TBII activity detected in all of the Graves' patients in the present study, it is possible that the increased NIS mRNA and protein concentrations in the corresponding thyroid tissue were attributable to increased cAMP accumulation induced by TBII. Increased expression of both NIS and TPO may contribute to the development of Graves' disease.
Investigation of the regulation of human NIS gene expression provides an important information that will be useful in defining the precise role of this protein and may, therefore, produce a practical approach to elucidate thyroid disease. EXPRESSION OF THE Na ϩ /I Ϫ SYMPORTER 3335
